
#1571Genetics & Molecular BiologyFront Page5 March 2026
The Next Era of Precision Oncology: How New Prostate Cancer Biomarkers Could Redefine Treatment
Early-stage research has identified an 11-gene signature capable of predicting aggressive prostate cancer. This preprint study suggests the CDC45 gene could serve as a major therapeutic target for future drug development.
By Xie, Wang, Gao
